HR 1725 · 114th Congress · Health
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
Bill Progress
✓
Introduced✓
Committee✓
House Vote4
Senate5
EnactedLatest: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.(2015-09-09)
Plain Language Summary
[AI summary unavailable — showing source text]
National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015 Amends the National All Schedules Prescription Electronic Reporting Act of 2005 to include as a purpose of state-administered controlled substance monitoring systems ensuring access to prescription history information for the investigative purposes of appropriate law enforcement, regulatory, and state professional licensing authorities. Amends the Public Health Service Act to revise and reauthorize through FY2020 the controlled substance monitoring program, including to: allow grants to be used to maintain and operate existing state controlled substance monitoring programs, require the Department of Health and Human Services (HHS) to redistribute any funds that are returned among the remaining grantees, require a state to provide HHS with aggregate data and other information to enable HHS to evaluate the success of the state's program, and expand the program to include any commonwealth or territory of the United States. Allows the Drug Enforcement Administration, HHS, a state Medicaid program, a state health department, or a state substance abuse agency receiving nonidentifiable information from a …
Summarized by Claude AI · Non-partisan · For informational purposes only
CBO Cost Estimate
Congressional Budget OfficeH.R. 1725, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2015
Aug 14, 2015As ordered reported by the House Committee on Energy and Commerce on July 29, 2015
Full CBO report ↗Official non-partisan budget analysis by the Congressional Budget Office
Cosponsors (13)
8 Democrats5 Republicans